Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) CEO Marcio Souza purchased 27,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 8th. The stock was bought at an average price of $1.85 per share, with a total value of $49,950.00. Following the completion of the purchase, the chief executive officer […]
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) Director Dean J. Mitchell acquired 25,000 shares of the company’s stock in a transaction on Wednesday, June 8th. The shares were acquired at an average price of $1.81 per share, for a total transaction of $45,250.00. Following the completion of the acquisition, the director now directly owns […]
Praxis Precision Medicines (NASDAQ:PRAX – Get Rating) had its target price lowered by stock analysts at HC Wainwright from $48.00 to $10.00 in a research note issued to investors on Tuesday, The Fly reports. HC Wainwright’s price objective suggests a potential upside of 431.91% from the company’s current price. A number of other brokerages have […]
Equities analysts expect Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) to announce earnings per share (EPS) of ($1.29) for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Praxis Precision Medicines’ earnings, with the lowest EPS estimate coming in at ($1.41) and the highest estimate coming in at ($1.18). Praxis […]
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) was the recipient of unusually large options trading on Friday. Traders acquired 4,727 call options on the stock. This represents an increase of 1,410% compared to the typical daily volume of 313 call options. Separately, HC Wainwright assumed coverage on Praxis Precision Medicines in a research note […]